ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,532, issued on Feb. 18, was assigned to Viatris Asia Pacific Ptd. Ltd. (Singapore).
"Crystalline forms" was invented by Daniel Leuenberger (Allschwil, Switzerland), Stefan Reber (Allschwil, Switzerland) and Markus Von Raumer (Allschwil, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to crystalline forms of 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline forms, pharmaceutical compositions prepared from such cry...